Thursday, November 13, 2025

AUTHOR NAME

Ave Marketaccess

10262 POSTS
0 COMMENTS

Innovative mHealth Tool Aims to Tackle Rising Dementia Cases in Peru

In the sprawling landscape of Peru, where the rate of dementia cases is climbing at an alarming pace, cutting-edge solutions are paramount. The IMPACT...

Understanding the Dynamics of Medicare Diagnosis Coding Practices

The insights into Medicare diagnosis coding reveal an intricate system that significantly influences healthcare funding and delivery. As the U.S. healthcare landscape increasingly relies...

Primary Healthcare Utilization Reduces Costs for Diabetic Patients in China

The significance of primary healthcare (PHC) in managing diabetes becomes an important area of exploration as China's healthcare system grapples with efficiency challenges. Amid...

A New Strategy to Fight Cardiovascular Disease: Evaluating FH Screening’s Costs and Benefits

Familial hypercholesterolemia (FH) silently increases the risk of cardiovascular disease (CVD) by elevating low-density lipoprotein cholesterol (LDL-C) from birth, yet many remain unaware of...

Experts Set New Guidelines for Treat-to-Target Strategy in Juvenile Dermatomyositis

Juvenile dermatomyositis (JDM), a challenging and uncommon autoimmune disorder, requires precise treatment strategies to improve patient outcomes. The treat-to-target (T2T) approach, emphasizing clear therapeutic...

Takeda Advances Mezagitamab in IgA Nephropathy Clinical Trials

Takeda has released promising interim data from its Phase 1b clinical study, showcasing the sustained efficacy of mezagitamab in primary IgA nephropathy treatment. This...

Olezarsen Shows Significant Promise in Reducing Severe Hypertriglyceridemia and Acute Pancreatitis

At the American Heart Association's 2025 Scientific Sessions, revolutionary findings emerged about olezarsen's potential in treating severe hypertriglyceridemia (sHTG). These groundbreaking results, presented as...

Austria Develops Groundbreaking Model for Social Prescribing in Primary Care

Austria is spearheading an innovative approach to healthcare with the development of a programme theory for social prescribing (SP) in primary care environments. Implemented...

Tirzepatide Outperforms in Weight and Glycemic Management

Recent advancements in the treatment of type 2 diabetes and obesity are drawing attention, particularly with the promising results of tirzepatide. As a dual-action...

Sleeplessness and Muscle Loss: A Double Threat to Brain and Function in Seniors

Recent insights into geriatric health have unveiled an intriguing confluence between two seemingly distinct conditions: insomnia and sarcopenia. While both conditions independently pose challenges...

US Military Servicewomen Face Challenges with Abortion Care Access

In an unexpected revelation, a study highlights the pressing issues faced by US military servicewomen regarding abortion care. The stringent abortion bans in several...

School Staff Struggle with Vaping Policies as Use Soars Among Students

Vaping continues to rise as the leading form of drug use among students in the United States, introducing significant challenges for educational institutions. With...

Dupixent Poised to Address Allergic Fungal Rhinosinusitis with Promising Phase 3 Results

Regeneron Pharmaceuticals, Inc. and Sanofi have announced impressive outcomes from their recent Phase 3 trial, showcasing the effectiveness of Dupixent in alleviating allergic fungal...

Cost-Effectiveness of CDK4/6 Inhibitors in Advanced Breast Cancer: Insights from the SONIA Trial

The fight against advanced breast cancer continues to challenge oncologists with decisions about optimal treatment pathways. The balance between efficacy and economic sustainability is...

Parental Factors Influence ADHD Diagnosis Reports in Germany

Understanding how parental perceptions affect the diagnosis reports of ADHD in children can reveal crucial dynamics between official statistics and the on-ground reality of...

Latest news